Macular hole after intravitreal bevacizumab injection for choroidal neovascularisation
| dc.contributor.author | Tufan, Hasan Ali | |
| dc.contributor.author | Gencer, Baran | |
| dc.contributor.author | Kara, Selcuk | |
| dc.date.accessioned | 2025-01-27T20:50:34Z | |
| dc.date.available | 2025-01-27T20:50:34Z | |
| dc.date.issued | 2014 | |
| dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
| dc.description.abstract | PurposeThe aim of this study was to report a patient who developed a full-thickness macular hole following intravitreal bevacizumab injection. MethodsA 78-year-old patient diagnosed with choroidal neovascularisation (CNV) was treated with intravitreal bevacizumab injection. ResultsOn the first follow-up visit, a decrease in visual acuity was seen and a small full-thickness macular hole with complete resolution of subretinal fluid was observed in optical coherence tomography (OCT). A second intravitreal injection of bevacizumab was performed. At the subsequent visit, a serious loss of visual acuity and limited regression in choroidal neovascularisation was seen. The OCT showed a larger full-thickness macular hole. ConclusionsThis case demonstrates that intravitreal bevacizumab injection might be responsible for the development of a macular hole. Clinicians should be cautious that a macular hole may be a complication of intravitreal bevacizumab injection. | |
| dc.identifier.doi | 10.1111/cxo.12009 | |
| dc.identifier.endpage | 180 | |
| dc.identifier.issn | 0816-4622 | |
| dc.identifier.issn | 1444-0938 | |
| dc.identifier.issue | 2 | |
| dc.identifier.pmid | 23331251 | |
| dc.identifier.scopus | 2-s2.0-84894297136 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 178 | |
| dc.identifier.uri | https://doi.org/10.1111/cxo.12009 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12428/25525 | |
| dc.identifier.volume | 97 | |
| dc.identifier.wos | WOS:000331698200013 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Taylor & Francis Ltd | |
| dc.relation.ispartof | Clinical and Experimental Optometry | |
| dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20250125 | |
| dc.subject | bevacizumab | |
| dc.subject | intravitreal injection | |
| dc.subject | macular hole | |
| dc.title | Macular hole after intravitreal bevacizumab injection for choroidal neovascularisation | |
| dc.type | Article |
